How Does Targeted Therapy Change the Treatment of EGFR-Mutated NSCLC?

The management of lung cancer now is not determined solely by the origin or stage of progression. There are modern diagnostic possibilities which allow the doctor to study the genetics of the tumor tissue. This discovery has affected the way some non-small cell lung cancer patients are managed. One of the most important genetic abnormalities is EGFR mutation. In case some mutations in EGFR are detected, there might be a new target of treatment for a patient. Drugs like Geftinat 250mg Tablet (Gefitinib) act as inhibitors of the EGFR pathway.

Why Does the Genetic Profile of Lung Cancer Matter?

Two patients can have NSCLC, but the way their tumors act might vary from the molecular point of view. Some cancer cells have a certain mutation, which constantly gives growth signals, such as those affecting the EGFR pathway. That is why in many cases when dealing with NSCLC, one needs to test a tumor at the molecular level first.

What Is The Role of Gefitinib in Cancer Treatment?

The tablet is one of the drugs belonging to EGFR tyrosine kinase inhibitor (TKI) class. EGFR can be thought of as a part of a communication mechanism that can provide growth signals to the cancer cells. There can be some EGFR mutations that could cause persistent growth signals. It acts by blocking EGFR tyrosine kinase function, which prevents the growth signals from reaching the cancer cells.

What Can Patients Expect During Treatment?

It is an oral form of medication that ensures administration of treatment without infusion of medicine into the body. The following aspects may be assessed during treatment by the medical team:

• Tumor response using imaging studies

• Clinical condition of the patient

• Hepatic functions

• Skin-related issues

• Gastrointestinal side-effects

• Presence of treatment-related complications

Proper follow-up is required to establish the efficacy of the therapy.

What Side Effects Can The Medicine Cause?

As the tablet impacts pathways that involve EGFR and are also expressed in normal tissues, some patients may develop adverse effects. Some common side effects may consist of:

• Skin rash

• Dermatitis

• Diarrhea

• Acneiform skin reactions

• Anorexia

• Nausea

• Asthenia

• Abnormalities in liver function tests

There are also some uncommon but possible serious adverse events. If a patient develops new breathing issues, severe diarrhea, eye symptoms, or any signs of liver abnormalities, they should consult a medical specialist without delay.

What Should Patients Know Before Buying The Tablet Online?

The patient seeking to Buy Geftinat 250mg Tablet (Gefitinib) in non small cell lung cancer is advised to know that medicine is a prescription drug used for treating cancer. However, when purchasing the tablet, it is recommended to obtain it only from a reputable pharmacy using the prescription offered by the oncologists. It is also recommended not to change the dosage without conducting EGFR tests.

Conclusion

Personalized medicine has brought about individualization of cancer treatments by harnessing information at the molecular level to determine the target for the treatment. In eligible patients of EGFR mutant NSCLC, the tablets can be prescribed as an EGFR targeted treatment based on their mutation and medical background. However, people looking to order the tablet should procure the medication from a legitimate source like Magicine Pharma, an online trusted pharmacy that also offer discount on their cancer medications.

FAQs

1. What is the significance of EGFR testing before starting the treatment?

The EGFR test determines whether the tumor has an EGFR mutation that would make the use of an EGFR-targeting drug indicated.

2. Is Gefitinib 250mg a chemotherapy drug?

No, it is not a chemotherapy drug. Rather, it is a tyrosine kinase inhibitor.